In October 2020, the FDA strengthened its warning about NSAID use during pregnancy. The updated guidance specifically states that NSAIDs can cause low amniotic fluid levels when used at approximately 20 weeks of gestation or later, and that this complication can occur after just days of NSAID use.
Low amniotic fluid can lead to serious complications including impaired fetal lung and kidney development, limb contractures, and in severe cases, fetal death. The FDA recommends that NSAIDs should be avoided at 20 weeks and later unless specifically prescribed by a provider for a condition where the benefits outweigh the risks.
Before 20 weeks, the evidence of harm is less clear, but since a safe and effective alternative exists (acetaminophen), most providers recommend avoiding ibuprofen throughout pregnancy.